Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Vibrio coralliilyticus T6SS comparative proteomics

ABSTRACT: Comparative proteomics to identify the proteins secreted by T6SS1 and T6SS2 of Vibrio coralliilyticus strains BAA-450, OCN008, and OCN014.

INSTRUMENT(S):

ORGANISM(S): Vibrio Coralliilyticus Atcc Baa-450 Vibrio Coralliilyticus Ocn008

SUBMITTER: Dor Salomon

LAB HEAD: Dor Salomon

PROVIDER: PXD049479 | Pride | 2024-02-29

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	Converstion_of_file_number_to_sample_name.xlsx	Xlsx
	Seq80359_88min_HF.raw	Raw
	Seq80360_88min_HF.raw	Raw
	Seq80361_88min_HF.raw	Raw
	Seq80362_88min_HF.raw	Raw

Items per page:

1 - 5 of 31

Similar Datasets

Comparative proteomics for the secretome of Vibrio proteolyticus T6SS3

Project description:Identifying the secreted effector proteins of type VI secretion system 3 (T6SS3) in the bacterium Vibrio proteolyticus.

2023-04-13 | PXD040610 | Pride

A-to-I mRNA editing enables bacteria to produce two protein versions from a single gene and affects bacterial growth

Project description:Adenosine-to-inosine (A-to-I) mRNA editing can affect the sequence and function of translated proteins because the ribosome reads inosine (I) as guanosine (G). Previously, we discovered that A-to-I mRNA editing occurs in Escherichia coli. However, the prevalence of A-to-I mRNA editing across bacteria and its biological significance are still unknown. Here, we show that A-to-I mRNA editing occurs in hundreds of genes across dozens of bacterial species. We find that editing events occur within and require a conserved sequence motif. Notably, most editing events (80%) are predicted to recode protein sequences. Indeed, by mass spectrometry, we show for the first time that A-to-I mRNA editing enables bacteria to produce two versions of a protein from a single gene. Finally, we find that perturbing mRNA editing in Acinetobacter baylyi affects bacterial growth, especially at high temperatures. Overall, our work reveals that A-to-I mRNA editing is widespread and can impact bacterial physiology, likely by modulating protein function

2025-07-21 | PXD051887 | Pride

LeishIF3d is a non-canonical cap-binding protein specific for Leishmania

Project description:Translation of most cellular mRNAs in eukaryotes proceeds through a cap-dependent pathway, whereby the cap-binding complex, eIF4F, anchors the pre-initiation complex at the 5’ end of mRNAs driving translation initiation. The genome of Leishmania encodes a large repertoire of cap-binding complexes that fulfill a variety of functions possibly involved in survival along the life cycle. However, most of these complexes function in the promastigote life form that resides in the sand fly vector and lose their activity in amastigotes, the mammalian life form. Here we examined the possibility that LeishIF3d drives translation in Leishmania using alternative pathways. We describe a non-canonical cap-binding activity of LeishIF3d and examine its potential role in driving translation. LeishIF3d is required for translation, as reducing its expression by a homozygous deletion reduces the translation activity of the LeishIF3d(+/-) mutant cells. Proteomic analysis of the mutant cells highlights the reduced expression of flagellar and cytoskeletal proteins, as reflected in the morphological changes observed in the mutant cells. Targeted mutations in two predicted alpha helices diminish the cap-binding activity of LeishIF3d. Overall, LeishIF3d could serve as a driving force for alternative translation pathways, although it does not seem to offer an alternative pathway for translation in amastigotes.

2023-07-20 | PXD040501 | Pride

Deciphering dermatological distinctions: Cornulin as a discriminant biomarker between Basal Cell Carcinoma and Squamous Cell Carcinoma detected through E-biopsy and Machine Learning

Project description:Background: Clinical misdiagnosis between cutaneous squamous cell carcinoma (cSCC) and basal cell carcinoma (BCC) poses treatment challenges and carries risks of recurrence, metastases, and increased morbidity and mortality. Objective: We aimed to identify discriminant proteins markers for cSCC and BCC using a minimally invasive proteome sampling method called e-biopsy, employing electroporation for non-thermal cell permeabilization and machine learning. Methods: E-biopsy facilitated ex vivo proteome extraction from 21 cSCC and 21 BCC pathologically validated human cancers. LC/MS/MS profiling of 126 proteomes was followed by Machine Learning analysis to identify proteins distinguishing cSCC from BCC. For identified panel validation, we used proteomes sampled by e-biopsy from unrelated 20 cSCC and 46 BCC human cancers, and differential expression analysis of published transcriptomics. The most commonly chosen discriminant biomarker by machine learning models, cornulin, was also validated using fluorescent immunohistochemistry. Results: 192 proteomes sampled from 108 patients were analyzed. Machine Learning-based approaches resulted in a set of 11 potential biomarker proteins that can be used to construct a model with 95.2% average cross-validation accuracy, BCC precision of 93.6±14.5%, cSCC precision of 98.4±7.2%, specificity of 97.7±11.8%, and per-patient sensitivity 92.7±15.3%. Protein-protein interaction analysis revealed a novel interaction network connecting 10 of the 11 resulted proteins. Histological and transcriptomic validation confirmed cornulin as a discriminant marker significantly lower in cSCC than in BCC. Conclusions: E-biopsy combined with machine learning provides a novel approach to molecular biomarkers sampling from skin for biomarker detection and differential expression analysis between cSCC and BCC

2024-08-22 | PXD050713 | Pride

Formation of a membraneless compartment regulates bacterial virulence

Project description:The RNA-binding protein CsrA regulates the expression of hundreds of genes in several bacterial species, thus controlling virulence and other processes. However, the outcome of the CsrA-mRNA interactions is modulated by competing small RNAs and other factors through mechanisms that are only partially understood. Here, we show that CsrA accumulates in a dynamic membraneless compartment in cells of E. coli and other pathogenic species. In addition to CsrA, the compartment contains components of the RNA-degrading complex (degradosome), regulatory small RNAs, and selected mRNAs. Formation of the compartment is associated with a switch between promoting and repressing virulence gene expression by CsrA. We suggest that similar CsrA switches may be widespread in diverse bacteria.

2025-05-07 | PXD061003 | Pride

Characterization of RBM10 interactome in unchallenged and MK1775-treated cells

Project description:Mapping of RBM10-interactome using GFP-trap purification of EGFP-RBM10 expressed in HEK293T cells before and after WEE1 inhibition by MK1775. HEK293T expressing EGFP only or EGFP-RBM10 fusion (2 main isoforms) were left untreated or treated with 300nM MK1775 for 4 hours prior to GFP-trap enrichment and mass spectrometry analysis.

2024-07-16 | PXD040109 | Pride

Expression profiling data from mid-log phase cultures of wild type Vibrio campbellii BAA-1116

Project description:Small RNA and regulatory RNA discovery has been based on (i) computational predictions mainly in intergenic regions, (ii) microarray experiments, (iii) shotgun cloning of cDNA libraries, (iv) classical cloning of abundant small RNAs after size fractionation in polyacrylamide gels and (v) copurification with proteins like Hfq, CsrA and RNA polymerase. In this study, we attempted to experimentally validate in silico small and regulatory RNA predictions for V. campbellii BAA-1116 using a microarray expression profiling strategy. Specifically, we investigated transcripts from mid-log phase cultures grown in nutrient rich media and examined their hybridization to tiled probes targeting annotated V. campbellii BAA-1116 intergenic regions. Keywords: small RNA discovery Five replicates of wild type V. campbellii BAA-1116 were grown to Mid-log phase, and total RNA was extracted from 1.0E+9 cells. Messenger RNA was isolated from the total RNA extracts treated with DNase, labeled with biotin, fragmented and hybridized to V. campbellii BAA-1116 whole genome microarray (520694F, Affymetrix).

2010-06-01 | E-GEOD-20960 | biostudies-arrayexpress

Comparative proteomic profiling reveals specific adaptation of Vibrio anguillarum to oxidative stress, iron deprivation and humoral components of innate immunity

Project description:The gram-negative bacterium Vibrio (Listonella) anguillarum is the causative agent of vibriosis, a bacterial disease affecting aquacultural industry across the globe. The full mechanism of V. anguillarum pathogenesis is not completely understood, but many virulence determinants have been identified. The current study aimed to obtain molecular insights into the proteome response of the bacterium to several conditions mimicking vibriosis. Our data shed light on the adaptability of V. anguillarum to oxidative stress, iron limitations and the complement system, and offer potential virulence determinants associated in particular with septicemia over the course of vibriosis.

2021-11-25 | PXD025367 | Pride

Aeromonas jandaei DSM 7311 T6SS secretome - comparative proteomics

Project description:Label-free quantification comparative proteomics analysis of proteins secreted to the media by the T6SS of Aeromonas jandaei DSM 7311

2024-08-13 | PXD054809 | Pride

MS-DAP platform for label-free proteomics uncovers optimal workflows in benchmark datasets and increased sensitivity in analysis of Alzheimer's biomarker data

Project description:In the rapidly moving proteomics field, a diverse patchwork of algorithms for data normalization and differential expression analysis is used by the community. We generated an all-inclusive mass spectrometry downstream analysis pipeline (MS-DAP) that integrates many algorithms for normalization and statistical analyses and produces standardized quality reporting with extensive data visualizations. Second, systematic evaluation of normalization and statistical algorithms on various benchmarking datasets, including additional data generated in this study, suggest best-practices for data analysis. Commonly used approaches for differential testing based on moderated t-statistics are consistently outperformed by more recent statistical models, all integrated in MS-DAP, and we encourage their adoption. Third, we introduced a novel normalization algorithm that rescues deficiencies observed in commonly used normalization methods. Finally, we used the MS-DAP platform to re-analyze a recently published large-scale proteomics dataset of CSF from AD patients. This revealed increased sensitivity, resulting in additional significant target proteins which improved overlap with results reported in related studies and includes a large set of new potential AD biomarkers in addition to previously reported.

2023-03-10 | PXD036134 | Pride